Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
Todd J. Anderson, Jean Grégoire, Robert A. Hegele, et al.
Canadian Journal of Cardiology (2013) Vol. 29, Iss. 2, pp. 151-167
Closed Access | Times Cited: 778

Showing 1-25 of 778 citing articles:

Guidelines for the Early Management of Patients With Acute Ischemic Stroke
Edward C. Jauch, Jeffrey L. Saver, Harold P. Adams, et al.
Stroke (2013) Vol. 44, Iss. 3, pp. 870-947
Open Access | Times Cited: 7448
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
David C. Goff, Donald M. Lloyd‐Jones, Glen C. Bennett, et al.
Journal of the American College of Cardiology (2013) Vol. 63, Iss. 25, pp. 2935-2959
Open Access | Times Cited: 4698
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
David C. Goff, Donald M. Lloyd‐Jones, Glen C. Bennett, et al.
Circulation (2013) Vol. 129, Iss. 25_suppl_2
Open Access | Times Cited: 3268
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Jennifer G. Robinson, Michel Farnier, Michel Krempf, et al.
New England Journal of Medicine (2015) Vol. 372, Iss. 16, pp. 1489-1499
Open Access | Times Cited: 2155
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
Marc S. Sabatine, Robert P. Giugliano, Stephen D. Wiviott, et al.
New England Journal of Medicine (2015) Vol. 372, Iss. 16, pp. 1500-1509
Open Access | Times Cited: 1423
2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
Todd J. Anderson, Jean Grégoire, Glen J. Pearson, et al.
Canadian Journal of Cardiology (2016) Vol. 32, Iss. 11, pp. 1263-1282
Closed Access | Times Cited: 1093
Overview of Epidemiology and Contribution of Obesity to Cardiovascular Disease
Marjorie Bastien, Paul Poirier, Isabelle Lemieux, et al.
Progress in Cardiovascular Diseases (2013) Vol. 56, Iss. 4, pp. 369-381
Closed Access | Times Cited: 1070
A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy
Dora Liu, Alexandra Ahmet, Leanne M. Ward, et al.
Allergy Asthma and Clinical Immunology (2013) Vol. 9, Iss. 1
Open Access | Times Cited: 1066
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Terry A. Jacobson, Kevin C. Maki, Carl E. Orringer, et al.
Journal of clinical lipidology (2015) Vol. 9, Iss. 6, pp. S1-S122.e1
Open Access | Times Cited: 744
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report
Terry A. Jacobson, Matthew K. Ito, Kevin C. Maki, et al.
Journal of clinical lipidology (2015) Vol. 9, Iss. 2, pp. 129-169
Closed Access | Times Cited: 729
The 2015 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension
Stella S. Daskalopoulou, Doreen M. Rabi, Kelly B. Zarnke, et al.
Canadian Journal of Cardiology (2015) Vol. 31, Iss. 5, pp. 549-568
Open Access | Times Cited: 688
2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults
Glen J. Pearson, George Thanassoulis, Todd J. Anderson, et al.
Canadian Journal of Cardiology (2021) Vol. 37, Iss. 8, pp. 1129-1150
Open Access | Times Cited: 633
Food groups and risk of coronary heart disease, stroke and heart failure: A systematic review and dose-response meta-analysis of prospective studies
Angela Bechthold, Heiner Boeing, Carolina Schwedhelm, et al.
Critical Reviews in Food Science and Nutrition (2017) Vol. 59, Iss. 7, pp. 1071-1090
Open Access | Times Cited: 580
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
Robert A. Hegele, Henry N. Ginsberg, M. John Chapman, et al.
The Lancet Diabetes & Endocrinology (2013) Vol. 2, Iss. 8, pp. 655-666
Open Access | Times Cited: 561
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults
Kirsten Bibbins‐Domingo, David C. Grossman, Susan J. Curry, et al.
JAMA (2016) Vol. 316, Iss. 19, pp. 1997-1997
Closed Access | Times Cited: 538
ATUALIZAÇÃO DA DIRETRIZ BRASILEIRA DE DISLIPIDEMIAS E PREVENÇÃO DA ATEROSCLEROSE - 2017
A.K.F. Faludi, Maria Cristina de Oliveira Izar, JFK Saraiva, et al.
Arquivos Brasileiros de Cardiologia (2017) Vol. 109, Iss. 1
Open Access | Times Cited: 513
Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target
Enrica Golia, Giuseppe Limongelli, Francesco Natale, et al.
Current Atherosclerosis Reports (2014) Vol. 16, Iss. 9
Closed Access | Times Cited: 493
Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia
Jennifer G. Robinson, Bettina S. Nedergaard, William J. Rogers, et al.
JAMA (2014) Vol. 311, Iss. 18, pp. 1870-1870
Closed Access | Times Cited: 469
National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary
Terry A. Jacobson, Matthew K. Ito, Kevin C. Maki, et al.
Journal of clinical lipidology (2014) Vol. 8, Iss. 5, pp. 473-488
Open Access | Times Cited: 455
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
Gerald F. Watts, Samuel S. Gidding, Anthony S. Wierzbicki, et al.
International Journal of Cardiology (2013) Vol. 171, Iss. 3, pp. 309-325
Open Access | Times Cited: 360
An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia
Scott M. Grundy, Hidenori Arai, Philip J. Barter, et al.
Journal of clinical lipidology (2013) Vol. 7, Iss. 6, pp. 561-565
Closed Access | Times Cited: 347
An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report
Scott M. Grundy, Hidenori Arai, Philip J. Barter, et al.
Journal of clinical lipidology (2013) Vol. 8, Iss. 1, pp. 29-60
Open Access | Times Cited: 313
The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011
Kausik K. Ray, John J.P. Kastelein, S. Matthijs Boekholdt, et al.
European Heart Journal (2014) Vol. 35, Iss. 15, pp. 960-968
Open Access | Times Cited: 294
Effects of Vegetarian Diets on Blood Lipids: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Fenglei Wang, Ju‐Sheng Zheng, Bo Yang, et al.
Journal of the American Heart Association (2015) Vol. 4, Iss. 10
Open Access | Times Cited: 294
A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study
Janie Allaire, Patrick Couture, Myriam Leclerc, et al.
American Journal of Clinical Nutrition (2016) Vol. 104, Iss. 2, pp. 280-287
Open Access | Times Cited: 230
Page 1 - Next Page

Scroll to top